This compound is primarily studied for its potential in neuroscience and pharmacology due to its structural similarity to ergoline derivatives, which are known for their psychoactive properties. It may interact with serotonin receptors, making it a candidate for research in treating neurological and psychiatric disorders such as depression, anxiety, or migraines. Additionally, its unique chemical structure could be explored for developing novel therapeutic agents targeting the central nervous system. Research is ongoing to understand its efficacy, safety, and potential applications in medicine.